A Guided Meditation Program in Patients Undergoing Dialysis
This is an open-label, single center, non-randomized, single-arm pilot study to determine the ability of a Relaxation and Guided Imagery Program for its ability to induce a reduction in anxiety in subjects undergoing hemodialysis for End Stage Renal Disease (ESRD). Measures will evaluate the program's ability to impact anxiety, with secondary analysis of headaches, insomnia, fatigue, and pain. Subjects will be administered questionnaires at the study start and study end. Intervention will involve listening to a pre-recorded guided relaxation and imagery during regularly-scheduled dialysis sessions for four weeks.
• Males and females; 18 years or older.
• Receiving hemodialysis at The Rogosin Institute for End Stage Renal Disease.
• Willingness to adhere to the treatment intervention schedule.
• Subjects must present with anxiety.
• Willing and able to provide informed consent.